Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The haemophilic community in Britain, already hit by HIV infection, is now facing the problem of chronic hepatitis C. The high incidence of hepatitis after treatment with clotting factor concentrate from a large pool was first identified by Kasper and Kipnis in 1972.1 They found that infection was more common in young patients having their first treatment. It is now known that there was virtually a 100% rate of transmission of hepatitis C virus to previously untreated patients with haemophilia until effective procedures to inactivate the virus were introduced in 1985-6.2 3 Transmission of hepatitis C occurred with plasma from NHS and commercial sources. Studies of the hepatitis C virus genotype found in British patients with haemophilia who have been treated with concentrates have shown types 1, 2, and 3, reflecting contamination from the British and North American donor pool. Type
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?